BE506218A - - Google Patents
Info
- Publication number
- BE506218A BE506218A BE506218DA BE506218A BE 506218 A BE506218 A BE 506218A BE 506218D A BE506218D A BE 506218DA BE 506218 A BE506218 A BE 506218A
- Authority
- BE
- Belgium
- Prior art keywords
- piperazine
- methyl
- carbamyl
- dialkyl
- compounds
- Prior art date
Links
- 239000002904 solvent Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 150000002978 peroxides Chemical class 0.000 description 4
- RCKMWOKWVGPNJF-UHFFFAOYSA-N diethylcarbamazine Chemical compound CCN(CC)C(=O)N1CCN(C)CC1 RCKMWOKWVGPNJF-UHFFFAOYSA-N 0.000 description 3
- 150000004965 peroxy acids Chemical class 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- KDKGWGUUUVROTO-UHFFFAOYSA-N 1-hydroxypiperazine Chemical class ON1CCNCC1 KDKGWGUUUVROTO-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- -1 aliphatic alcohols Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- XRDQHFPGJJMNFN-UHFFFAOYSA-N 1-ethyl-1-oxidopiperazin-1-ium Chemical class CC[N+]1([O-])CCNCC1 XRDQHFPGJJMNFN-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000000641 filaricidal effect Effects 0.000 description 1
- 239000003664 filaricide agent Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- OUVVCIBIGUCHRM-UHFFFAOYSA-N n,n,4-trimethylpiperazine-1-carboxamide Chemical compound CN(C)C(=O)N1CCN(C)CC1 OUVVCIBIGUCHRM-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/24—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE506218A true BE506218A (de) |
Family
ID=146542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE506218D BE506218A (de) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE506218A (de) |
-
0
- BE BE506218D patent/BE506218A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0110781A1 (de) | Substituierte (Amino-2-ethyl)-6-Benzoxazolinone, ihre Herstellung und pharmazeutische Zusammenstellung die sie enthält | |
| EP0239461A1 (de) | N-¬¬(Hydroxy-2-phenyl)(phenyl)methylen amino-2 äthylacetamid-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Heilmittel | |
| BE506218A (de) | ||
| MC1332A1 (fr) | Nouveaux derives de quinazoline et preparations pharmaceutiques | |
| EP0143016B1 (de) | Derivate von 4-(3-Alkynyloxy-2-hydroxy-propyl)-piperazin-1-yl-N-phenylacetamid, ihre Herstellung und ihre therapeutische Verwendung | |
| EP0070753A1 (de) | 10-(Aza-1-bicyclo(2,2,2)octyl-3)-10H-Phenothiazin-sulfonamid-2, und seine Derivate | |
| EP0047207B1 (de) | N-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamide, Verfahren zur Herstellung und Verwendung als Heilmittel | |
| MC1387A1 (fr) | Nouveaux derives de phenoxyaminopropanol et leur preparation | |
| BE830534A (fr) | O-acyl-acrylaldoximes substituees, leur preparation et leurs applications | |
| EP0061379B1 (de) | Pyridinderivate, ihre Herstellung und ihre therapeutische Anwendung | |
| EP0037777B1 (de) | Verfahren zur Herstellung von als Heilmittel verwendbaren Cycloalcoyl-propanol-aminen | |
| EP0216646A2 (de) | N,N-Dimethylethylaminoxidderivat, Herstellungsverfahren und pharmazeutische Mittel | |
| FR2551751A1 (fr) | Nouveau procede de preparation d'un derive pyroglutamique, nouveaux derives pyroglutamiques, nouveaux intermediaires de synthese de preparation de ceux-ci et utilisation ou application des derives pyroglutamiques comme agents antibacteriens ou antifongiques | |
| CA1093078A (fr) | Derives de l'hydroxy-4 thiazolidinethione-2, leur preparation et les compositions qui les contiennent | |
| FR2479814A1 (fr) | Phenyl alcoxy propanolamines, leur preparation et leur application en tant que medicaments | |
| FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
| BE492921A (de) | ||
| BE503775A (de) | ||
| CH394701A (fr) | Procédé de préparation de nouveaux esters phosphoriques et utilisation de ceux-ci | |
| CH359697A (fr) | Procédé de préparation de nouveaux dérivés de l'éthylène et utilisation de ces dérivés | |
| FR2584402A2 (fr) | Nouveaux derives d'(arylpiperazinylethylaminoethoxy)-4 phenols, leur methode de preparation et leur application therapeutique | |
| CH329720A (fr) | Procédé de préparation de nouveaux dérivés de l'éthylène et utilisation de ces dérivés | |
| FR2564463A1 (fr) | Nouveaux derives heterocycliques, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase | |
| CH351280A (fr) | Procédé de préparation de la 6-diazo-5-oxo-norleucine | |
| BE574132A (de) |